Amara Therapeutics launches virtual urinary incontinence clinic

Digital Therapeutics company Amara Therapeutics has announced the launch of Dry Days Health, a first-of-its kind virtual clinic dedicated to women living with urinary incontinence, one of the most under-treated yet prevalent conditions affecting women worldwide.

Amara Therapeutics is a women’s health company developing digital therapeutics and virtual care solutions for pelvic and bladder health conditions, including urinary incontinence and overactive bladder. 

The new virtual clinic is now live in Indiana and Maryland, with plans for rapid expansion across the US in 2026. 

For millions of women, urinary incontinence is more than a medical issue, it’s a hidden  struggle that affects every aspect of daily life.

From avoiding exercise or social events to worrying about leaks at work or while caring for family, the condition quietly limits confidence, independence, and opportunity.

It’s also one of the leading contributors to anxiety and depression among midlife women, yet too often goes unspoken.

Despite its prevalence, fewer than half of women ever receive specialist care, largely due to stigma,  cost, and a shortage of accessible pelvic and bladder health professionals leaving many to manage alone with over-the-counter pads instead of proven, lasting treatments. 

Dry Days Health directly addresses these barriers by providing next-day virtual appointments with specialist licensed clinicians delivering personalised, evidence-based treatment plans from the comfort and privacy of home.

Dr Jennifer Bepple is Dry Days Health medical director.

She said: “Urinary incontinence is very common but is not a normal part of aging and women deserve better care.

“With Dry Days, we’re combining the accessibility of telemedicine  with the precision of digital health to finally close the treatment gap for women’s pelvic and bladder health.” 

Each patient receives one-on-one care from a licensed clinician along with access to Amara’s app-based pelvic health programme, a set of clinically informed exercises, education, and tracking tools designed to help women strengthen their pelvic and bladder health and stay engaged in their recovery journey.

Together, these components form a comprehensive, accessible pathway to better outcomes and improved quality of life.

The clinic’s initial rollout in Indiana and Maryland will serve as the foundation for nationwide expansion in 2026, with partnerships under development with leading health systems. 

Brendan Staunton is CEO of Amara Therapeutics.

He said: “Dry Days Health isn’t just improving access to care, it’s redefining how women engage with their health.

“With Dry Days Health, we’re proving that accessible, high-quality pelvic health care can scale nationally.

“We’re building a model that makes specialist women’s care intuitive and connected, improving outcomes for patients and efficiency for providers.”

To learn more or to book an appointment, visit www.drydays.health